Skip to main content

Table 5 Predictivity of cytokines and chemokines in SLE flares

From: Predictive biological markers of systemic lupus erythematosus flares: a systematic literature review

Cytokines or chemokines

Number of patients (n)

Findings

Study

BAFF/BLyS

42

Changes in BAFF levels were unrelated to disease flares

Becker-Merok et al., 2006 [47]

BAFF/BLyS

245

Increase in BLyS level was associated with the occurrence of mild-to-moderate flares

Petri et al., 2008 [48]

BAFF/BLyS

562

Baseline BLyS level independently predicted flare

Petri et al., 2013 [9]

BLyS, APRIL and 50 analytes: innate and adaptive cytokines, chemokines and soluble TNFR superfamily members

28

Patients with impending flare had significant alterations in the levels of 27 soluble mediators at baseline

Munroe et al., 2014 [52]

CCL2 (MCP-1), CCL19 (MIP-3B), CXCL10 (IP-10)

267

Patients with high baseline chemokine levels were at increased risk for flares

Bauer et al., 2009 [49]

CXCL2, CXCL10

25

High CXCL10 and CXCL2 were predictive of increased disease activity

Andrade et al., 2012 [50]

IL-2R

26

Activation of T cells occurs prior to clinical disease activity

Spronk et al., 1996 [56]

sIL-2R

NA

Levels of sIL-2R rose significantly up to the moment of maximal disease activity

Spronk et al., 1994 [57]

sCD25

3

Levels of sCD25 increased preceding periods of exacerbations

Swaak et al., 1995 [55]

IFN-α, IFN-γ-inducible protein 1 and sialic acid-binding Ig-like lectin 1

79

None of the investigated biomarkers was a predictive variable for flares

Rose et al., 2013 [51]

Soluble IL-7 receptor (sIL-7R)

105

High sIL-7R levels associated with renal flares

Lauwerys et al., 2014 [53]

IL1-RA, TNFRI

41

Patients who flared had higher baseline plasma levels of IL-1RA and TNFRI

Guthridge et al., 2014 [54]

  1. APRIL a proliferation-inducing ligand, BAFF B-cell activating factor, BLyS B-lymphocyte stimulator, CCL chemokine ligand, CXCL chemokine (C–X–C motif) ligand, s soluble, SLE systemic lupus erythematosus, TNFR tumour necrosis factor receptor type